Nectar Lifesciences (NSE:NECLIFE) Operating Margin %: 0.00% (As of Mar. 2026)


NSE:NECLIFE Nectar Lifesciences Ltd NSE:NECLIFE
43 GF Score
Price ₹11.42
GF Value ₹6.82
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Nectar Lifesciences Operating Margin %?

Nectar Lifesciences NSE:NECLIFE -1.04% 43 Operating Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:NECLIFE with a GF Score™ of 43/100 and a GF Value™ of ₹6.82 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 952 Drug Manufacturers companies, Nectar Lifesciences ranks worse than 88.45% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Nectar Lifesciences's Operating Income for the three months ended in Mar. 2026 was ₹-573 Mil. Nectar Lifesciences's Revenue for the three months ended in Mar. 2026 was ₹0 Mil. Therefore, Nectar Lifesciences's Operating Margin % for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Nectar Lifesciences's Operating Margin % or its related term are showing as below:

NSE:NECLIFE' s Operating Margin % Range Over the Past 10 Years
Min: -48.4   Med: 6.41   Max: 9.88
Current: -48.4


NSE:NECLIFE's Operating Margin % is ranked worse than
88.45% of 952 companies
in the Drug Manufacturers industry
Industry Median: 7.58 vs NSE:NECLIFE: -48.40

Nectar Lifesciences's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Nectar Lifesciences's Operating Income for the three months ended in Mar. 2026 was ₹-573 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-1,382 Mil.


Nectar Lifesciences  (NSE:NECLIFE) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Nectar Lifesciences Operating Margin % Related Terms


Nectar Lifesciences Operating Margin % Historical Data

* Premium members only.

The historical data trend for Nectar Lifesciences's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nectar Lifesciences Operating Margin % Chart

Nectar Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.09 -0.34 5.49 0.00 0.00

Nectar Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -27.94 -10.66 0.00 0.00

NSE:NECLIFE vs ZTS: Operating Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nectar Lifesciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nectar Lifesciences Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nectar Lifesciences's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Nectar Lifesciences's Operating Margin % falls into.


NSE:NECLIFE
43GF Score
Nectar Lifesciences Ltd NSE:NECLIFE
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nectar Lifesciences Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Nectar Lifesciences's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=-590.341 / 0
= %

Nectar Lifesciences's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-573.184 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
Nectar Lifesciences (NSE:NECLIFE) has a Operating Margin % of 0.00% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Nectar Lifesciences and its competitors. According to the industry distribution chart, Nectar Lifesciences ranks #842 out of 952 companies in the Drug Manufacturers industry, placing it in the top 88.4%.
Is Nectar Lifesciences' Operating Margin % too high?
Nectar Lifesciences' current Operating Margin % is 0.00%. Based on the distribution chart, Nectar Lifesciences ranks #842 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Nectar Lifesciences has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nectar Lifesciences' Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Nectar Lifesciences ranks #842 out of 952 companies for Operating Margin %. This places Nectar Lifesciences in the lower half of its industry. The industry median Operating Margin % is 7.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Nectar Lifesciences and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nectar Lifesciences's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nectar Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Nectar Lifesciences (NSE:NECLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹6.82, compared to a current price of ₹11.42 — trading 67.4% above its estimated fair value. The current Operating Margin % is 0.00%. Nectar Lifesciences' overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Nectar Lifesciences (NSE:NECLIFE), the current Operating Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nectar Lifesciences (NSE:NECLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Nectar Lifesciences stock appears to be overvalued. The current stock price of ₹11.42 is trading 67.4% above its estimated GF Value™ of ₹6.82. GuruFocus considers Nectar Lifesciences to be Significantly Overvalued.

Key valuation signals for NSE:NECLIFE:

  • Operating Margin %: 0.00%
  • GF Value™: ₹6.82 vs. price of ₹11.42 (67.4% above fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the NSE:NECLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nectar Lifesciences Business Description

Other Exchanges 532649:India
Address S.C.O. 38-39, Sector 9-D, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company specializing in Cephalosporins. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products. The Company is also in the Menthol business and succeeded in both domestic and international markets. Its business areas are APIs, Formulations, and Empty Hard Gelatin Capsules. Geographically, it derives a majority of its revenue from India.
43GF Score

Get the complete analysis for NSE:NECLIFE

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.42
Price
₹6.82
GF Value